Back to search

United Kingdom· GB-APID-3812011000001105

Nupercainal 1.1% ointment

A cinchocaine product containing cinchocaine, registered in United Kingdom by Boston Healthcare Ltd. The same ATC class is registered in 2 of our 19 countries.

ATC D04AB02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedNupercainal 1.1% ointmentATCD04AB02REGISTER NO.GB-APID-3812011000001…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Cinchocaine is registered in 2 of 19 countries.

Countries holding a registration under ATC D04AB02 (cinchocaine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)

Cinchocaine · ATC D04AB02

2 / 19 countries

  • Germany
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Cinchocaine
Manufacturer
Boston Healthcare Ltd
Country
United Kingdom (GB)
ATC code
D04AB02
ATC class
Cinchocaine
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5050768140017

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

41 interactions on record for cinchocaine.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cinchocaine · interactions on record

41 records

  • 1 severe
  • 40 moderate

Most severe, free to view

  • PrilocaineN01BB04severe
  • MetoclopramideA03FA01moderate
  • SulfamethizoleB05CA04moderate
  • LidocaineC01BB01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cinchocaine in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cinchocaine products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Germany · Cincain, Doloposterine N Salbe
  • Finland · Orodrops
  • Greece · Otaset
  • Italy · Cincocaina Cloridrato Allergeaze Smartpractice Europe
  • Portugal · Nupercainal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aad3eaf0-a447-43ed-adbf-cff2ceeb545c
GET /v1/drugs/aad3eaf0-a447-43ed-adbf-cff2ceeb545c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "3812011000001105",
  "desc": "Nupercainal 1.1% ointment (Boston Healthcare Ltd)",
  "form": "Cutaneous ointment",
  "vpid": "41894211000001104",
  "source": "dmd",
  "vtm_id": "775251002",
  "strength": "11 mg",
  "substance": "Cinchocaine",
  "ingredient": "Cinchocaine hydrochloride",
  "supplier_code": "20595711000001100"
}

See everything about cinchocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.